These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 12871204)
21. Novel concepts of statin therapy for cardiovascular risk reduction in hypertension. Varughese GI; Patel JV; Lip GY; Varma C Curr Pharm Des; 2006; 12(13):1593-609. PubMed ID: 16729872 [TBL] [Abstract][Full Text] [Related]
22. Drug therapy for the secondary prevention of stroke in hypertensive patients: current issues and options. Lüders S Drugs; 2007; 67(7):955-63. PubMed ID: 17488141 [TBL] [Abstract][Full Text] [Related]
23. Does hypertension confer a prothrombotic state? Virchow's triad revisited. Lip GY; Blann AD Circulation; 2000 Jan; 101(3):218-20. PubMed ID: 10645912 [No Abstract] [Full Text] [Related]
24. Cancer and the prothrombotic state. Lip GY; Chin BS; Blann AD Lancet Oncol; 2002 Jan; 3(1):27-34. PubMed ID: 11908507 [TBL] [Abstract][Full Text] [Related]
25. Role of hypertension in atherosclerosis and cardiovascular disease. Hollander W Am J Cardiol; 1976 Nov; 38(6):786-800. PubMed ID: 136891 [TBL] [Abstract][Full Text] [Related]
26. The endothelium and atrial fibrillation. The prothrombotic state revisited. Freestone B; Lip GY Hamostaseologie; 2008 Oct; 28(4):207-12. PubMed ID: 18836646 [TBL] [Abstract][Full Text] [Related]
27. Hypertension: renin-angiotensin-aldosterone system alterations. Te Riet L; van Esch JH; Roks AJ; van den Meiracker AH; Danser AH Circ Res; 2015 Mar; 116(6):960-75. PubMed ID: 25767283 [TBL] [Abstract][Full Text] [Related]
28. Platelet indexes in relation to target organ damage in high-risk hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). Nadar SK; Blann AD; Kamath S; Beevers DG; Lip GY J Am Coll Cardiol; 2004 Jul; 44(2):415-22. PubMed ID: 15261941 [TBL] [Abstract][Full Text] [Related]
29. The effects of antihypertensive therapy on haemostatic parameters. Ganotakis ES; Papadakis JA; Vrentzos GE; Mikhailidis DP Curr Pharm Des; 2003; 9(29):2445-64. PubMed ID: 14529558 [TBL] [Abstract][Full Text] [Related]
30. Effect of long-term celiprolol therapy on haemostasis in essential hypertension. Okrucká A; Pechán J; Kratochvílová H J Hum Hypertens; 1995 Sep; 9(9):773-6. PubMed ID: 8551493 [TBL] [Abstract][Full Text] [Related]
31. Virchow's triad revisited: the importance of soluble coagulation factors, the endothelium, and platelets. Blann AD; Lip GY Thromb Res; 2001 Feb; 101(4):321-7. PubMed ID: 11320984 [No Abstract] [Full Text] [Related]
32. The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension. Thomas GN; Chan P; Tomlinson B Drugs Aging; 2006; 23(2):131-55. PubMed ID: 16536636 [TBL] [Abstract][Full Text] [Related]
33. [Retrospective studies and prospects of therapy for hypertension]. Maisch B; Brilla C; Kruse T; Noll B; Bethge C Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697 [TBL] [Abstract][Full Text] [Related]
34. Target organ damage in hypertension: pathophysiology and implications for drug therapy. Nadar SK; Tayebjee MH; Messerli F; Lip GY Curr Pharm Des; 2006; 12(13):1581-92. PubMed ID: 16729871 [TBL] [Abstract][Full Text] [Related]